The company, founded in 2008 and based in Ann Arbor, Michigan, aims to improve the performance and reduce complications and costs of critical medical device interventions by developing nitric oxide generating coatings. These coatings address issues related to clotting and altered healing, and Accord Biomaterials also provides catalytic nitric oxide sensor systems to accurately measure nitric oxide levels in plasma and blood.